Fig. 1From: Inconsistent approaches of the G-BA regarding acceptance of primary study endpoints as being relevant to patients - an analysis of three disease areas: oncological, metabolic, and infectious diseasesPatient relevance of PEPs according to the G-BA by endpoint dimension. a All three therapeutic areas, b oncological diseases, c metabolic diseases, and d infectious diseases. HRQoL was not used as PEP for any assessment, therefore it is not shown in the graphsBack to article page